Literature DB >> 22801674

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Virginia A Moyer.   

Abstract

DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer.
METHODS: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer. RECOMMENDATION: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801674     DOI: 10.7326/0003-4819-157-2-201207170-00459

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  731 in total

Review 1.  Serum markers in prostate cancer detection.

Authors:  Ola Bratt; Hans Lilja
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

2.  Prostate cancer: New PSA screening guideline faces widespread opposition.

Authors:  Sarah Payton
Journal:  Nat Rev Urol       Date:  2012-06-05       Impact factor: 14.432

3.  Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Authors:  Sigrid Carlsson; Andrew J Vickers; Monique Roobol; James Eastham; Peter Scardino; Hans Lilja; Jonas Hugosson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

4.  Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.

Authors:  Shivani Pahwa; Nicholas K Schiltz; Lee E Ponsky; Ziang Lu; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-05-17       Impact factor: 11.105

5.  African american primary care physicians' prostate cancer screening practices.

Authors:  Louie E Ross; Ingrid J Hall
Journal:  J Prim Care Community Health       Date:  2013-10-17

Review 6.  Future directions in the prevention of prostate cancer.

Authors:  Ian M Thompson; April B Cabang; Michael J Wargovich
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

7.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

8.  Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.

Authors:  Soroush Rais-Bahrami; Barış Türkbey; Ardeshir R Rastinehad; Annerleim Walton-Diaz; Anthony N Hoang; M Minhaj Siddiqui; Lambros Stamatakis; Hong Truong; Jeffrey W Nix; Srinivas Vourganti; Kinzya B Grant; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

9.  Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.

Authors:  Roxanne Espaldon; Katharine A Kirby; Kathy Z Fung; Richard M Hoffman; Adam A Powell; Stephen J Freedland; Louise C Walter
Journal:  Urology       Date:  2014-01-16       Impact factor: 2.649

10.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.